Fifteen percent of 318 diabetic foot infections studied involved methicillin-resistant Staphylococcus aureus, but 86% of the patients in the study were prescribed antibiotics to treat MRSA, according to a study in PLOS ONE.
Section 361 human cell and tissue products do not have to undergo the FDA premarket approval process but can claim to be equally or more effective than FDA-approved wound therapies, potentially affecting clinical decisions that could lead to lower-limb amputation, writes Jack Richmond, interim president and CEO at the Amputee Coalition. "The Amputee Coalition believes the FDA must prevent unsubstantiated and misleading promotional claims made by manufacturers of Section 361 HCT/Ps, and expand adverse event reporting for these products to the same level required for drugs and medical devices, to ensure their efficacy and safety," Richmond writes.
A hemostatic device based on self-assembling peptide technology was found to be safe and stanched bleeding in skin lesions faster than standard care in a clinical study, according to manufacturer Arch Therapeutics.
Physicians will have four Quality Payment Program options next year under the Medicare Access and CHIP Reauthorization Act, acting CMS Administrator Andy Slavitt wrote in a blog post. Physicians can choose to test the program, participate for part of the year or for the full year, or participate in an alternative payment model such as an accountable care organization.
The American Medical Association, the American College of Surgeons, and societies representing orthopedic and neurological surgeons are among the organizations objecting to a CMS proposal that surgeons use new billing codes to document their work in 10-minute segments during 10-day and 90-day global surgical packages. Surgeons would have to document the number and level of pre- and postoperative visits in every global package using "G" codes that describe 10 minutes of care, which surgeons say does not reflect real-world conditions.
Excellent firms don't believe in excellence -- only in constant improvement and constant change.
Tom Peters, writer and management consultant
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes.